936 related articles for article (PubMed ID: 19348791)
1. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
Hussein MR
Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
[TBL] [Abstract][Full Text] [Related]
2. c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma.
Fulop V; Mok SC; Genest DR; Szigetvari I; Cseh I; Berkowitz RS
J Reprod Med; 1998 Feb; 43(2):101-10. PubMed ID: 9513871
[TBL] [Abstract][Full Text] [Related]
3. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression.
Wong SY; Ngan HY; Chan CC; Cheung AN
Mod Pathol; 1999 Nov; 12(11):1025-33. PubMed ID: 10574599
[TBL] [Abstract][Full Text] [Related]
5. p53 expression in placentas with hydropic change and hydatidiform moles.
Cheville JC; Robinson RA; Benda JA
Mod Pathol; 1996 Apr; 9(4):392-6. PubMed ID: 8729978
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 and p53 expressions in Indian women with complete hydatidiform mole.
Rath G; Soni S; Prasad CP; Salhan S; Jain AK; Saxena S
Singapore Med J; 2011 Jul; 52(7):502-7. PubMed ID: 21808961
[TBL] [Abstract][Full Text] [Related]
7. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
[TBL] [Abstract][Full Text] [Related]
8. Expression of the p53 gene and apoptosis in gestational trophoblastic disease.
Halperin R; Peller S; Sandbank J; Bukovsky I; Schneider D
Placenta; 2000 Jan; 21(1):58-62. PubMed ID: 10692252
[TBL] [Abstract][Full Text] [Related]
9. Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease.
Persaud V; Ganjei P; Nadji M
West Indian Med J; 1993 Dec; 42(4):142-3. PubMed ID: 7909185
[TBL] [Abstract][Full Text] [Related]
10. Decidual immune cell infiltrate in hydatidiform mole.
Hussein MR; Abd-Elwahed AR; Abodeif ES; Abdulwahed SR
Cancer Invest; 2009 Jan; 27(1):60-6. PubMed ID: 19160109
[TBL] [Abstract][Full Text] [Related]
11. P63 expression in gestational trophoblastic disease: correlation with proliferation and apoptotic dynamics.
Zhang HJ; Xue WC; Siu MK; Liao XY; Ngan HY; Cheung AN
Int J Gynecol Pathol; 2009 Mar; 28(2):172-8. PubMed ID: 19188816
[TBL] [Abstract][Full Text] [Related]
12. Placental Fas and Fas ligand expression in normal early, term and molar pregnancy.
Pongcharoen S; Searle RF; Bulmer JN
Placenta; 2004 Apr; 25(4):321-30. PubMed ID: 15028424
[TBL] [Abstract][Full Text] [Related]
13. Expression of the p53 gene in trophoblastic cells in hydatidiform moles and normal human placentas.
Cheung AN; Srivastava G; Chung LP; Ngan HY; Man TK; Liu YT; Chen WZ; Collins RJ; Wong LC; Ma HK
J Reprod Med; 1994 Mar; 39(3):223-7. PubMed ID: 8035377
[TBL] [Abstract][Full Text] [Related]
14. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
[TBL] [Abstract][Full Text] [Related]
15. Trophoblast subtype-specific EGFR/ERBB4 expression correlates with cell cycle progression and hyperplasia in complete hydatidiform moles.
Fock V; Plessl K; Fuchs R; Dekan S; Milla SK; Haider S; Fiala C; Knöfler M; Pollheimer J
Hum Reprod; 2015 Apr; 30(4):789-99. PubMed ID: 25740878
[TBL] [Abstract][Full Text] [Related]
16. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
Kale A; Söylemez F; Ensari A
Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
[TBL] [Abstract][Full Text] [Related]
17. The villous stromal constituents of complete hydatidiform mole differ histologically in very early pregnancy from the normally developing placenta.
Kim KR; Park BH; Hong YO; Kwon HC; Robboy SJ
Am J Surg Pathol; 2009 Feb; 33(2):176-85. PubMed ID: 18936691
[TBL] [Abstract][Full Text] [Related]
18. P63 expression in hydropic abortion and gestational trophoblastic diseases.
Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
[TBL] [Abstract][Full Text] [Related]
19. Biology of human trophoblast.
Mochizuki M; Maruo T; Matsuo H; Samoto T; Ishihara N
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S21-8. PubMed ID: 9833611
[TBL] [Abstract][Full Text] [Related]
20. Expression of epidermal growth factor in gestational trophoblastic disease (GTD).
John M; Rajalekshmy TN; Nair MB; Augustine J; Schultz G; Nair MK; Balaram P
J Exp Clin Cancer Res; 1997 Jun; 16(2):129-34. PubMed ID: 9261736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
